December 19, 2024

FDA Redefines 'Healthy' Food Claims

The regulation requires qualifying foods to contain amounts from at least one food group or subgroup referenced in the Dietary Guidelines for Americans.

Conexiant

December 19, 2024

FDA Rejects New Bowel Disease Drug

The FDA declined to approve Zealand Pharma's bowel disease drug and sought an additional trial to confirm the drug's safety and efficacy, impacting thousands of adult patients in the United States.

Reuters

December 18, 2024

Physicians With Kids Face Large Pay Gaps

Physician compensation remains a central concern in health care, influenced by educational debt, specialty-specific variations, and evolving employer policies.

Conexiant

December 17, 2024

FDA Targets Unapproved GLP-1 Drug Sellers

The FDA has issued warning letters to companies for selling unapproved versions of popular diabetes and weight-loss drugs. The companies falsely labeled products for 'research use only' despite evidence showing they are intended for human use.

Reuters

December 17, 2024

Teva Sanofi Drug Hits IBD Trial Goals

"These unprecedented results show that duvakitug could represent the next frontier in treating ulcerative colitis and Crohn’s disease."

Reuters

December 16, 2024

Probiotics' Limits Revealed in Major Review

"Current evidence does not support the notion that probiotics can restore the microbiota to its pre-antibiotic state."

Conexiant

December 16, 2024

Migraine Medicine May Help Gut Disorders

A genetic analysis published in Neurology Genetics revealed significant shared genetic connections between migraine and various gastrointestinal disorders, suggesting avenues for targeted treatment through the CGRP pathway.

Conexiant

December 16, 2024

Colon Cancer's Hidden Inflammatory Signature Found

Researchers have identified a significant breakdown in the body's natural inflammation-resolution process in colorectal cancer, where tumor cells maintain a chronic inflammatory state by failing to switch from pro-inflammatory to inflammation-resolving lipids, potentially opening new therapeutic pathways.

Conexiant

December 12, 2024

Melanoma Recurrence Signs with ATLAS Guide

Study published in the Journal of the American Academy of Dermatology explores key symptoms and detection strategies for melanoma recurrence, providing potential improvements for surveillance protocols.

Conexiant